Xuhui Yuan

The novel prognostic risk factor STC2 can regulate the occurrence and progression of osteosarcoma via the glycolytic pathway

Bo Yu, Feifei Zhang, Lang Liu et al. · Biochemical and Biophysical Research Communications · 2021 · 29 citations

Medicine, Cancer Biology, Oncology +13

Stabilization of SAMHD1 by NONO is crucial for Ara-C resistance in AML

Feifei Zhang, Jun Sun, Xiaofeng Tang et al. · Cell Death and Disease · 2022 · 20 citations · Full text

Medicine, Cancer Biology, Oncology +14

Optogenetic activation of mechanical nociceptions to enhance implant osseointegration

Q. Wang, Yang Chen, Haiqi Ding et al. · Nature Communications · 2025 · 20 citations · Full text

Engineering, Bioengineering, Biomedical Engineering +17

The synergistic anticancer effect of the bromodomain inhibitor OTX015 and histone deacetylase 6 inhibitor WT-161 in osteosarcoma

Bo Yu, Lang Liu, Feng Cai et al. · Cancer Cell International · 2022 · 18 citations · Full text

Medicine, Oncology, Pharmacology +16

Indirect bilirubin impairs invasion of osteosarcoma cells via inhibiting the PI3K/AKT/MMP-2 signaling pathway by suppressing intracellular ROS

Xuhui Yuan, Cong Ma, Jiayu Li et al. · Journal of bone oncology · 2023 · 17 citations · Full text

Medicine, Oncology, Pharmacology +17